Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: Maastricht Radiation Oncology
Condition: Glioblastoma, Astrocytoma, Grade IV
NCT02432417
The Addition of Chloroquine to Chemoradiation for Glioblastoma,
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
The study was withdrawn due to a lack of funding. The researchers were unable to secure the necessary financial support to continue and complete the trial.